NCT06568172 2026-04-16
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
Clinical Trials
15 trialsNCT05691478 2026-04-15
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
National Cancer Institute (NCI)
Phase 2/3 Recruiting
NCT07301268 2026-04-08
GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma
Mayo Clinic
Phase 2 Recruiting
NCT04031677 2026-03-31
STRASS2
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Recruiting
NCT04890067 2026-03-27
ISG Os2Oss
Italian Sarcoma Group
Recruiting
NCT05950594 2026-03-16
IVIM & OLINK in Sarcoma
University Health Network, Toronto
Phase 2 Recruiting
NCT04845893 2026-01-02
EWOss
Italian Sarcoma Group
Recruiting
NCT06835049 2025-12-30
TNT-HYPE
Swiss Cancer Institute
Phase 2 Recruiting
NCT03896620 2025-12-24
Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma
Medical College of Wisconsin
Recruiting
NCT02789384 2025-12-02
NEOSarcomics
Institut Bergonié
Phase NA Recruiting
NCT07227961 2025-11-13
PROMIS and Mobility Evaluation in Sarcoma Patients
University of Calgary
Recruiting
NCT03978039 2025-09-04
BCB-Sarcomes
Institut Bergonié
Recruiting
NCT00005095 2025-02-28
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Northwestern University
Recruiting
NCT04699292 2022-08-30
International Prospective Registry on Local Treatment Approaches in MLS
The Netherlands Cancer Institute
Recruiting
NCT05373810 2022-05-23
Registration Study Sarcoma
Radboud University Medical Center
Recruiting